[go: up one dir, main page]

AU2003251875A1 - Combination therapy for the treatment of neoplasms - Google Patents

Combination therapy for the treatment of neoplasms

Info

Publication number
AU2003251875A1
AU2003251875A1 AU2003251875A AU2003251875A AU2003251875A1 AU 2003251875 A1 AU2003251875 A1 AU 2003251875A1 AU 2003251875 A AU2003251875 A AU 2003251875A AU 2003251875 A AU2003251875 A AU 2003251875A AU 2003251875 A1 AU2003251875 A1 AU 2003251875A1
Authority
AU
Australia
Prior art keywords
neoplasms
treatment
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003251875A
Other versions
AU2003251875A8 (en
Inventor
Benjamin A. Auspitz
Curtis Keith
Margaret S. Lee
M. James Nichols
Grant R. Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zalicus Inc
Original Assignee
CombinatoRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CombinatoRx Inc filed Critical CombinatoRx Inc
Publication of AU2003251875A8 publication Critical patent/AU2003251875A8/en
Publication of AU2003251875A1 publication Critical patent/AU2003251875A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003251875A 2002-07-15 2003-07-14 Combination therapy for the treatment of neoplasms Abandoned AU2003251875A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39612002P 2002-07-15 2002-07-15
US60/396,120 2002-07-15
US40090502P 2002-08-02 2002-08-02
US60/400,905 2002-08-02
PCT/US2003/021783 WO2004007676A2 (en) 2002-07-15 2003-07-14 Combination therapy for the treatment of neoplasms

Publications (2)

Publication Number Publication Date
AU2003251875A8 AU2003251875A8 (en) 2004-02-02
AU2003251875A1 true AU2003251875A1 (en) 2004-02-02

Family

ID=30118565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003251875A Abandoned AU2003251875A1 (en) 2002-07-15 2003-07-14 Combination therapy for the treatment of neoplasms

Country Status (2)

Country Link
AU (1) AU2003251875A1 (en)
WO (1) WO2004007676A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2456269A1 (en) * 2001-08-23 2003-03-06 The Government Of The United States Of America Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
AU2004298761A1 (en) * 2003-12-19 2005-06-30 Novartis Ag Combination of (a) N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor and the use thereof
JP5401849B2 (en) * 2008-06-30 2014-01-29 山陽色素株式会社 Pigment dispersion for color filters
US20110212176A1 (en) * 2008-10-31 2011-09-01 University Health Network Ciclopirox and cytarabine for the treatment of leukemic disorders
CA2801003A1 (en) * 2010-06-01 2011-12-08 Biotheryx, Inc. Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone
AU2011261499B2 (en) 2010-06-01 2015-07-16 Biotheryx, Inc. Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
IT1405078B1 (en) * 2010-06-23 2013-12-16 Quattrone COMPOUNDS FOR THE TREATMENT OF TUMORS WHICH CARRY MYC DEREGOLATE ONCOPROTEINS
US10231965B2 (en) 2014-02-20 2019-03-19 Ignyta, Inc. Molecules for administration to ROS1 mutant cancer cells
CN107206012A (en) * 2014-11-11 2017-09-26 堪萨斯大学 Method of treating bladder cancer with ciclopirox, ciclopirox amine, or ciclopirox prodrug
WO2016089760A1 (en) * 2014-12-02 2016-06-09 Ignyta, Inc. Combinations for the treatment of neuroblastoma
BR112018012255A2 (en) 2015-12-18 2018-12-04 Ignyta Inc method to treat cancer
BR112020000793A2 (en) 2017-07-19 2020-07-14 Ignyta, Inc. pharmaceutical compositions and dosage forms
CN111225662B (en) 2017-10-17 2022-11-22 伊尼塔公司 Pharmaceutical compositions and dosage forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
WO1993007902A1 (en) * 1991-10-16 1993-04-29 Richardson-Vicks, Inc. Enhanced skin penetration system for improved topical delivery of drugs
US5846984A (en) * 1996-01-19 1998-12-08 The Trustees Of Columbia University In The City Of New York Use of ciclopirox or a pharmaceutically acceptable salt thereof for inhibiting neuronal cell damage or neuronal cell death

Also Published As

Publication number Publication date
WO2004007676A2 (en) 2004-01-22
AU2003251875A8 (en) 2004-02-02
WO2004007676A3 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2003249244A1 (en) Methods for the treatment of neoplasms
IL164599A0 (en) Combination therapy for the treatment of cancer
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
AU2003300791A1 (en) Combination therapy for the treatment of pain
ZA200500618B (en) Combinations of drugs for the treatment of neoplasms
AU2003224654A1 (en) Photodynamic therapy for pre-melanomas
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
ZA200408767B (en) Immunoconjugates for the treatment of tumours
IL159887A0 (en) Combination therapy for the treatment of cancer
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003903387A0 (en) Combination therapy for treatment of neoplasia
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
EP1651211A4 (en) Combination of drugs for the treatment of neoplasms
GB0223367D0 (en) Therapeutic treatment
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
AU2003247005A1 (en) Therapy combination
GB0213869D0 (en) The treatment of pain
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
GB0223854D0 (en) Therapeutic treatment
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2002304883A1 (en) Device for the treatment of tumours
GB0210464D0 (en) Therapeutic treatment